These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 21602259)

  • 1. The changes in plasma retinol-binding protein 4 levels are associated with those of the apolipoprotein B-containing lipoproteins during dietary and drug treatment.
    Christou GA; Tellis CC; Elisaf MS; Tselepis AD; Kiortsis DN
    Angiology; 2012 Jan; 63(1):67-75. PubMed ID: 21602259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between retinol-binding protein 4 and apolipoprotein B-containing lipoproteins is attenuated in patients with very high serum triglycerides: A pilot study.
    Christou GA; Tellis CC; Elisaf MS; Tselepis AD; Kiortsis DN
    Hormones (Athens); 2016; 15(1):99-105. PubMed ID: 27086684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated retinol binding protein 4 induces apolipoprotein B production and associates with hypertriglyceridemia.
    Liu Y; Chen H; Wang J; Zhou W; Sun R; Xia M
    J Clin Endocrinol Metab; 2015 May; 100(5):E720-8. PubMed ID: 25781360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between serum retinol-binding protein 4 and small dense low-density lipoprotein cholesterol levels in young adult women.
    Usui S; Ichimura M; Ikeda S; Okamoto M
    Clin Chim Acta; 2009 Jan; 399(1-2):45-8. PubMed ID: 18782570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fenofibrate improves the atherogenic lipid profile and enhances LDL resistance to oxidation in HIV-positive adults.
    Badiou S; Merle De Boever C; Dupuy AM; Baillat V; Cristol JP; Reynes J
    Atherosclerosis; 2004 Feb; 172(2):273-9. PubMed ID: 15019537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association among retinol-binding protein 4, small dense LDL cholesterol and oxidized LDL levels in dyslipidemia subjects.
    Wu J; Shi YH; Niu DM; Li HQ; Zhang CN; Wang JJ
    Clin Biochem; 2012 Jun; 45(9):619-22. PubMed ID: 22426023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of non-high-density lipoprotein cholesterol and low-density lipoprotein cholesterol with apolipoprotein B during simvastatin + fenofibrate therapy in patients with combined hyperlipidemia (a subanalysis of the SAFARI trial).
    Grundy SM; Vega GL; Tomassini JE; Tershakovec AM
    Am J Cardiol; 2009 Aug; 104(4):548-53. PubMed ID: 19660610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum retinol-binding protein 4 concentration and its ratio to serum retinol are associated with obesity and metabolic syndrome components in children.
    Aeberli I; Biebinger R; Lehmann R; L'allemand D; Spinas GA; Zimmermann MB
    J Clin Endocrinol Metab; 2007 Nov; 92(11):4359-65. PubMed ID: 17726085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retinol-binding protein 4 is an independent factor associated with triglycerides and a determinant of very low-density lipoprotein-apolipoprotein B100 catabolism in type 2 diabetes mellitus.
    Vergès B; Guiu B; Cercueil JP; Duvillard L; Robin I; Buffier P; Bouillet B; Aho S; Brindisi MC; Petit JM
    Arterioscler Thromb Vasc Biol; 2012 Dec; 32(12):3050-7. PubMed ID: 23087360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High density lipoprotein is positively correlated with the changes in circulating total adiponectin and high molecular weight adiponectin during dietary and fenofibrate treatment.
    Christou GA; Tellis KC; Elisaf MC; Tselepis AD; Kiortsis DN
    Hormones (Athens); 2012; 11(2):178-88. PubMed ID: 22801564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retinol-binding protein 4 : a possible role in cardiovascular complications.
    Mohapatra J; Sharma M; Acharya A; Pandya G; Chatterjee A; Balaraman R; Jain MR
    Br J Pharmacol; 2011 Dec; 164(8):1939-48. PubMed ID: 21585349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The APOA5-1131 T>C variant enhances the association between RBP4 and hypertriglyceridemia in diabetes.
    Cabré A; Lázaro I; Girona J; Manzanares JM; Marimón F; Plana N; Guardiola M; Heras M; Masana L
    Nutr Metab Cardiovasc Dis; 2010 May; 20(4):243-8. PubMed ID: 19765959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term fenofibrate therapy increases fibroblast growth factor 21 and retinol-binding protein 4 in subjects with type 2 diabetes.
    Ong KL; Rye KA; O'Connell R; Jenkins AJ; Brown C; Xu A; Sullivan DR; Barter PJ; Keech AC;
    J Clin Endocrinol Metab; 2012 Dec; 97(12):4701-8. PubMed ID: 23144467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of orlistat and fenofibrate, alone or in combination, on small dense LDL and lipoprotein-associated phospholipase A2 in obese patients with metabolic syndrome.
    Filippatos TD; Gazi IF; Liberopoulos EN; Athyros VG; Elisaf MS; Tselepis AD; Kiortsis DN
    Atherosclerosis; 2007 Aug; 193(2):428-37. PubMed ID: 16911813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoprotein B-48 as a determinant of endothelial function in obese subjects with type 2 diabetes mellitus: effect of fenofibrate treatment.
    Chan DC; Wong AT; Yamashita S; Watts GF
    Atherosclerosis; 2012 Apr; 221(2):484-9. PubMed ID: 22341868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fenofibrate reduces serum retinol-binding protein-4 by suppressing its expression in adipose tissue.
    Wu H; Wei L; Bao Y; Lu J; Huang P; Liu Y; Jia W; Xiang K
    Am J Physiol Endocrinol Metab; 2009 Apr; 296(4):E628-34. PubMed ID: 19088257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of weight loss on LDL and HDL kinetics in the metabolic syndrome: associations with changes in plasma retinol-binding protein-4 and adiponectin levels.
    Ng TW; Watts GF; Barrett PH; Rye KA; Chan DC
    Diabetes Care; 2007 Nov; 30(11):2945-50. PubMed ID: 17686833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of fenofibrate on plasma lipoprotein composition and kinetics in patients with complete hepatic lipase deficiency.
    Ruel IL; Lamarche B; Mauger JF; Badellino KO; Cohn JS; Marcil M; Couture P
    Arterioscler Thromb Vasc Biol; 2005 Dec; 25(12):2600-7. PubMed ID: 16224048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of exercise training on circulating retinol-binding protein 4 and cardiovascular disease risk factors in obese men.
    Numao S; Sasai H; Nomata Y; Matsuo T; Eto M; Tsujimoto T; Tanaka K
    Obes Facts; 2012; 5(6):845-55. PubMed ID: 23258073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possible resting metabolic rate modification by the circulating RBP4 in obese subjects.
    Ansar H; Mirzaei K; Malek A; Najmafshar A; Hossein-nezhad A
    Diabetes Metab Syndr; 2015; 9(1):19-23. PubMed ID: 25450816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.